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The endosomal sorting complex required for
transport-I (ESCRT-I) complex, which is con-
served from yeast to humans, directs the
lysosomal degradation of ubiquitinated trans-
membrane proteins and the budding of the HIV
virus. Yeast ESCRT-I contains four subunits,
Vps23, Vps28, Vps37, and Mvb12. The crystal
structure of the heterotetrameric ESCRT-I com-
plex reveals a highly asymmetric complex of
1:1:1:1 subunit stoichiometry. Thecore complex
is nearly 18 nm long and consists of a headpiece
attached to a 13 nm stalk. The stalk is important
for cargo sorting by ESCRT-I and is proposed to
serve as a spacer regulating the correct disposi-
tion of cargo and other ESCRT components.
Hydrodynamic constraints and crystallographic
structures were used to generate a model of
intact ESCRT-I in solution. The results show
howESCRT-I uses a combination of a rigid stalk
and flexible tethers to interact with lipids, cargo,
and other ESCRT complexes over a span of
25 nm.
INTRODUCTION
The endosomal sorting complexes required for transport
(ESCRTs) direct transmembrane proteins into inwardly
budding vesicles at the multivesicular body (MVB) (Babst,
2005; Conibear, 2002; Hurley and Emr, 2006; Slagsvold
et al., 2006). Sorting into the MVB pathway is a key step
in the regulated degradation of transmembrane proteins
in the lysosome or yeast vacuole. The ESCRT network is
required for the downregulation of many cell surfacereceptors, for the delivery of resident hydrolases during
lysosome and vacuole biogenesis, and for the production
of exosomes from human cells (Katzmann et al., 2002).
ESCRT complexes participate in the budding of HIV-1
and a number of other viruses (Demirov and Freed,
2004; Morita and Sundquist, 2004).
The ESCRT proteinswere discovered as the products of
class E vacuolar protein sorting (VPS) genes in the bud-
ding yeast Saccharomyces cerevisiae (Bowers and Ste-
vens, 2005). Class E vpsmutants have a characteristic en-
larged cargo-rich compartment adjacent to the vacuole.
Yeast class E VPS genes encode the subunits of at least
four hetero-oligomeric protein complexes: the Vps27/
Hse1 complex and ESCRT-I, -II, and -III (Bowers and Ste-
vens, 2005; Hurley and Emr, 2006). Whereas monomeric
ESCRT-III components are believed to assemble at the
endosomal membrane, the other three complexes are as-
sembled in the cytosol and cycle on and off membranes.
Each of these soluble complexes contains specific ubiqui-
tin binding domains that recognize ubiquitinated cargo
proteins (Bilodeau et al., 2002; Hicke et al., 2005; Hurley
et al., 2006; Katzmann et al., 2001; Shih et al., 2002; Slags-
vold et al., 2005). Vps27/Hse1 (Katzmann et al., 2003) and
ESCRT-II (Slagsvold et al., 2005; Teo et al., 2006) contain
lipid binding domains that target these complexes to en-
dosomal membranes. P(S/T)XP sequences in Vps27
bind to the ubiquitin E2 variant domain of the ESCRT-I
subunit Vps23 (Bilodeau et al., 2003; Katzmann et al.,
2003), whereas the C-terminal domain of the ESCRT-I
subunit Vps28 binds to ESCRT-II (Kostelansky et al.,
2006; Teo et al., 2006). Collectively, these interactions
direct the assembly of the ESCRT network on endosomal
membranes.
ESCRT-I contains the subunits Vps23, Vps28, and
Vps37 and plays a central role in the MVB pathway (Katz-
mann et al., 2001). Human Vps23 (Tsg101) is one of
a handful of ESCRT proteins whose knockdown by RNA
interference almost completely blocks HIV buddingCell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc. 485
(Garrus et al., 2001). The structure and function of ESCRT-
I has come under intense scrutiny, and the structures
of many of its components have been determined. The
N-terminal UEV domains of yeast and human Vps23 have
been determined in complex with ubiquitin (Sundquist
et al., 2004; Teo et al., 2004b) and, for the human case,
with a PTAP motif peptide from HIV-1 (Pornillos et al.,
2002). The C-terminal domain of Vps28, responsible for
binding to ESCRT-II, is a four-helix bundle (Pineda-Molina
et al., 2006).
The structure of a globular core complex comprising the
C-terminal steadiness box of Vps23, the N-terminal half of
Vps28, and the C-terminal half of Vps37 showed how the
three subunits assemble together (Kostelansky et al.,
2006; Teo et al., 2006). However, the structures and func-
tions of the central region of Vps23 and the N-terminal half
of Vps37, both conserved from yeast to man, have yet to
be characterized. Furthermore, ESCRT-I isolated from
yeast has an apparent molecular weight of 350 kDa as
judged by gel filtration (Katzmann et al., 2001), yet near
full-length recombinant ESCRT-I purified from E. coli has
an apparent molecular weight of only200 kDa (Kostelan-
sky et al., 2006; Teo et al., 2006). This discrepancy led to
the question as to whether ESCRT-I in yeast oligomerizes
or contains additional subunits.
Here we identify a fourth ESCRT-I subunit, Mvb12, and
characterize the structure and function of the quaternary
Vps23:Vps28:Vps37:Mvb12 ESCRT-I complex. The com-
plete recombinant ESCRT-I complex migrates on gel fil-
tration in a manner identical to native yeast ESCRT-I and
has a 1:1:1:1 subunit stoichiometry. We determined the
crystal structure of the core of the complete heterotetra-
meric complex, which includes a novel 130 A˚-long stalk.
The integrity of the stalk is essential for sortingMVB cargo.
Hydrodynamic analysis of full-length and multiple trunca-
tion constructs was used in combination with crystal
structures to determine the conformation of intact ESCRT-I
in solution. The physical interactions of ESCRT-I with
membranes were inventoried and used to model the
structure of ESCRT-I bound to an endosomal membrane.
RESULTS
Mvb12 Is the Fourth Subunit of ESCRT-I
Genome-wide phenotypic profiling was used to identify
mutants defective in the sorting of carboxypeptidase Y
(CPY) (E.C., unpublished data). Known ESCRT-associ-
ated factors, including the VPS4-regulatory genes VTA1
and DID2, and the Vps27/Hse1 component HSEI, were
found in a cluster enriched for genes that encode endo-
some-localized proteins, including the ORF YGR206w
(E.C., unpublished data), which was also identified in an-
other screen for CPY sorting mutants (Bonangelino
et al., 2002). Coclustering with ESCRT regulatory factors
suggests this endosome-associated ORF, which is now
known as Mvb12, could play a role in sorting at the
MVB.mvb12Dmutants have a weak CPY missorting phe-486 Cell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc.notype compared to that of vps4D strains (Figure 1A). In
wild-type cells, Mvb12-GFP was diffusely localized, with
faint punctate staining (Figure 1B); however, in vps4D
mutants, Mvb12-GFP was found in brighter puncta that
colocalized with FM4-64, a characteristic of ESCRT com-
ponents. mvb12D mutants also exhibited defects in MVB
cargo sorting similar to those of ESCRT mutants (Fig-
ure 1C). The cargo proteins Ste3 and Sna3 largely failed
to reach the vacuole lumen in mvb12D mutants and
instead accumulated in aberrant MVB structures and at
the vacuole-limiting membrane. Each mvb12D mutant
phenotype was fully complemented by a MVB12-encod-
ing plasmid. The strong Ste3 and Sna3 mislocalization
phenotypes suggest that Mvb12 is important for sorting
MVB cargo.
Mvb12 Is a Component of the ESCRT-I Complex
Because ESCRT complexes are recruited to the MVB in
a stepwise fashion, the localization of Mvb12 in represen-
tative mutants provides a way to evaluate its association
with a particular ESCRT complex. Mvb12 was found at
the enlarged MVB in ESCRT-II (vps22D and vps36D) and
ESCRT-III (vps20D) mutants, indicating that recruitment
of Mvb12 is independent of these ESCRT complexes (Fig-
ures 1D and S1A). Mvb12was diffusely localized in Vps27/
Hse1 (vps27D) mutants and in mutants lacking two dif-
ferent components of ESCRT-I (vps23D and vps37D).
The recruitment of Mvb12-GFP to FM4-64-labeled endo-
somes was completely blocked in either vps27D vps4D
or vps23D vps4D double mutants and restored upon intro-
duction of a complementing plasmid-borne copy of
VPS27 or VPS23, respectively (Figure 1B).
The physical interaction between Mvb12 and the
ESCRT-I subunit Vps23 was tested by coimmunoprecipi-
tation of tagged proteins from cell lysates. Mvb12 and
Vps23 copurified efficiently, with immunoprecipitation of
80% of the cellular Vps23 resulting in the coprecipitation
of a nearly equal proportion (70%) of cellular Mvb12 (Fig-
ure 1E; lane 3). These findings are consistent with the
physical association of Mvb12 with ESCRT-I components
in proteome-wide screens of yeast protein complexes
(Gavin et al., 2006; Krogan et al., 2006). Unexpectedly,
loss of the ESCRT-I subunit Vps28 resulted in an en-
hanced MVB recruitment of Mvb12, similar to that seen
in ESCRT-II and -III mutants (Figure 1D). The copurifica-
tion of Mvb12 and Vps23 required Vps37, but not Vps28
(Figure 1E; lanes 8–10). Mvb12 thus appears to associate
with a stable, MVB-localized Vps23/37 subcomplex in
vps28Dmutants. Although ESCRT-I is found both in cyto-
sol and membrane-bound pools, the amount of Mvb12
that coprecipitated with Vps23 was unchanged in
vps27D mutants, in which ESCRT-I is entirely cytosolic,
compared to vps4D strains, where it is primarily endo-
some localized (Figure 1E; lanes 4 and 5). This indicates
that Mvb12 does not preferentially associate with a spe-
cific subcellular fraction of ESCRT-I. Taken together,
these data support the model that Mvb12 is an integral
component of the ESCRT-I complex.
Figure 1. Identification of the Novel
ESCRT-I Subunit Mvb12
(A) mvb12mutants exhibit a weak CPY-sorting
defect. CPY missorting from wild-type, vps4D,
ormvb12D strains with and without anMVB12-
expressing plasmid (+pMVB12) was detected
by colony overlay assay (Conibear and
Stevens, 2002).
(B)Mvb12 is recruited to the endosome in vps4D
mutants. vps27Dvps4D and vps23Dvps4D
strains containing integrated Mvb12-GFP and
plasmid-expressed VPS27 and VPS23, or
empty vector, were incubated with FM4-64
and viewed by double-label fluorescence
microscopy.
(C) Fluorescence microscopy of wild-type and
mvb12D strains containing Ste3-GFP, Sna3-
GFP, or ALP-GFP plasmids together with a
complementing MVB12 plasmid or empty
vector.
(D) Mvb12 recruitment does not require
ESCRT-II or -III. The chromosomal copy of
MVB12 was tagged with GFP in wild-type,
vps27D, vps23D, vps37D, vps28D, vps22D,
and vps20D strains and visualized in live cells.
(E) Mvb12 is associated with ESCRT-I. Deter-
gent extracts prepared from 20 OD600 units
(lanes 1–7) or 100 OD600 (lanes 8–10) of wild-
type or mutant strains expressing GFP-tagged
Mvb12 and/or HA-tagged Vps23 were immu-
noprecipitated with anti-HA antiserum and an-
alyzed by western blotting with anti-GFP and
anti-HA mAbs. Loading of lanes 9 and 10 was
7.53 greater than lane 8 to compare relative
levels of copurifyingMvb12-GFPdespite differ-
ences in Vps23 stability. Bar = 2 mM.Structure of the Heterotetrameric ESCRT-I
Core Complex
The structure of a heterotetrameric core complex of
ESCRT-I was determined at a nominal resolution of
2.7 A˚ (Figure 2A; Table S1). The heterotetrameric core
ESCRT-I structure consists of a globular headpiece at-
tached to an extended stalk (Figure 2B). The overall struc-
ture is 176 A˚ long. The headpiece is a flattened blade of
25 3 55 3 60 A˚ that corresponds to the ESCRT-I ternary
core complex (Figures 2C–2E) (Kostelansky et al., 2006;
Teo et al., 2006). The stalk is a cylinder of 20 A˚ diameter
bent gently into a 130 A˚ long S-shaped curve. The head-
piece includes portions of all four subunits, while the stalk
contains regions of Vps23, Vps37, and Mvb12, but not
Vps28 (Figures 2F–2H). Consistent with the finding that
Mvb12 forms a subcomplex in vivo with Vps23 andVps37, but not Vps28, the Mvb12:Vps28 interface buries
a negligible amount of solvent accessible surface area,
68 A˚2 (Figure 4). By contrast, Mvb12 buries 1470 and
2318 A˚2, respectively, in its interfaces with Vps23 and
Vps37. In total, Mvb12 buries a remarkable 42% of its sol-
vent-accessible surface area in the complex, leaving no
doubt that it is an integral core component of ESCRT-I.
The headpiece is built around three antiparallel two-
helix hairpins (Figures 2C–2E) and superimposes well
with the ternary core (rmsd of 0.8 A˚ for 193 Ca positions).
Residues of Vps28 that correspond to a3 in the ternary
core are disordered in this structure, while Vps28 helix
a4 is in a completely different position than in the ternary
core. Mvb12 contributes its N-terminal a1 helix to the
headpiece. The headpiece contains a two-stranded anti-
parallel b sheet (Figure 2F), not present in the ternaryCell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc. 487
Figure 2. Structure of the ESCRT-I Heterotetramer Core
(A) Electron density from the density-modified experimental map (blue) contoured at 1.0 s and from a Se anomalous difference Fourier contoured at
4.0 s (yellow) overlaid on the refined structure in the region of the helix bundle at the distal end of the stalk.
(B) Structure of ESCRT-I, Vps23, orange, Vps28, blue, Vps37, green, Mvb12, purple.
(C–E) Structure of the headpiece in the heterotetramer, shown with (D) the previously determined trimeric core structure in the same orientation. The
two structures are overlaid in (E) with the heterotetramer headpiece colored as in (C) and the trimer colored cyan.
(F) The headpiece contains a small b sheet near its junction with the stalk.
(G) The triple coiled coil is continued and stabilized by an unusual hybrid between a two-stranded coiled coil and an extended region of Mvb12.
(H) The helix bundle at the base of the stalk. Structural figures were generated with Pymol (http://www.pymol.org).complex. Mvb12-b1 (residues 14–16) is antiparallel to
Vps23 residues 317–319. This miniature b sheet connects
the headpiece to the stalk.
The stalk is centered on four long a helices, two from
Vps23, and one each from Vps37 and Mvb12 (Figures
2B, S2, and S3). The Vps23 a1 and a2 helices are nearly
colinear and run the entire length of the stalk (Figure 2B).
A short 310 helix (residues 247–253) separates these two
a helices. The a4 helix of Vps37 is nearly as long. Mvb12
contributes its a2 helix to the stalk (Figure 3A). These three
long helices come together to form a triple coiled coil over
part of their lengths (Figure 2G). Vps23 residues 254–265,
Vps37 residues 89–106, and Mvb12 residues 43–61 form488 Cell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc.a triple coiled coil in which Vps23 and Vps37 are parallel
and Mvb12 antiparallel. The triple coiled coil comprises
the center of the stalk. Proximal to the headpiece, Vps23
a2 and Vps37 a4 form an unusual partnering (the ‘‘hybrid’’)
with an extended portion of Mvb12, residues 18–39 (Fig-
ures 3C and 3D). Here Mvb12 contributes a series of hy-
drophobic residues to stabilize the groove between
Vps23 and Vps37 (Figure 3D). At the base of the stalk, dis-
tal to the headpiece, helices a2 and a3 of Vps37 form
a small four-helix bundle with the N terminus of Vps23
a1 and the C terminus of Mvb12 a2 (Figures 2H and 3A).
The very N-terminal helix a1 of Vps37 is not part of the
stalk at all. It is not directly associated with the rest of
Figure 3. Interactionswithin the ESCRT-I
Heterotetramer
(A, B, and D) Close ups of the interface of
Mvb12 (purple ribbon and stick model) with
Vps23, Vps28, and Vps37 (orange, blue, and
green surfaces, respectively).
(C) Shows locations of the regions of the
ESCRT-I heterotetramer highlighted in panels
(A), (B), and (D). Mvb12 residues are labeled
in white, while significant Vps23 residues are
labeled in black and Vps37 residues in red.
(E) Surface depiction of the ESCRT-I hetero-
tetramer showing in dark-blue residues highly
conserved in orthologs of Vps23, Vps28, and
Vps37. Mvb12 is depicted as a ribbon. The
conservation of the Mvb12 interaction surface
on the rest of the stalk suggests that there is
a structural counterpart of Mvb12 in nonfungal
species.the protein and is apparently trapped in an ordered con-
formation due to lattice contacts. A well-ordered sulfate
ion is bound in the stalk region by Vps37 His-71, His-73,
and Gln-74, suggestive of a potential phospholipid inter-
action site. However, the overall electronegative char-
acter of the stalk argues against a direct interaction with
membranes.
Stoichiometry and Solution Conformation
of ESCRT-I
The full-length heterotetrameric ESCRT-I complex con-
sisting of intact Vps23, Vps28, Vps37, and Mvb12 runs
on gel filtration chromatography with an apparent molec-
ular weight of 340 kDa (Figure 4B), identical within error to
the 350 kDa previously reported for native ESCRT-I
isolated from S. cerevisiae (Katzmann et al., 2001). Sedi-
mentation equilibrium centrifugation analysis revealed
that full-length ESCRT-I sample has an experimental mo-
lecular mass of 117 ± 4.6 kDa (Figure 4C and Table S2), as
compared to a calculated molecular mass for a 1:1:1:1
heterotetramer of 108 kDa. The experimental molecular
mass is consistent with a ‘‘monomeric’’ complex of n =
1.08 ± 0.04 and is inconsistent with any higher oligomeric
structures.The stoichiometry and solution conformation of intact
ESCRT-I was characterized by sedimentation velocity
experiments on intact heterotetrameric ESCRT-I and two
truncated constructs (Figure 4A and Table S2). The fric-
tional ratio of intact ESCRT-I, f/fo, is 1.9 ± 0.1. Globular
proteins have f/fo values ranging from 1.05 to 1.35,
whereas rod-like particles have f/fo values of 3 and larger.
The elongated shape of ESCRT-I in solution quantitatively
predicts its elution volume on gel filtration chromatogra-
phy (Figure S2). The solution conformations of the Vps23
UEV domain, the Vps28 C-terminal domain, and the
Vps37 N-terminal helix were assigned on the basis of iter-
ative modeling of the three experimental values for the
Stokes radii RH (Figure 4A). The best fit for the double-
deletion construct was obtained by modeling the N termi-
nus of Vps37 in a partially extended conformation (Fig-
ure 4D). The experimental Stokes radii rule out a ‘‘closed’’
conformation in which the UEV or Vps28 C-terminal
domain contacts the core in solution. In the absence
of Mvb12, the heterotrimeric UEV-domain deletion of
ESCRT-I has an experimental Stokes radius RH =
4.97 nm and a frictional ratio of 1.8, indicating ESCRT-I
retains an extended structure. On the other hand, if the
length and stability of the stalk were fully maintained in
the absence of Mvb12, this would yield a calculatedCell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc. 489
Figure 4. Stoichiometry and Solution Structure of the Complete ESCRT-I Complex
(A) Domain structure of full-length ESCRT-I and other constructs used in this study and their Stokes radii RH as determined by analytical ultracentri-
fugation.
(B) Gel filtration of full-length ESCRT-I, monitored at 280 nm. The inset shows aCoomassie blue-stained SDS-PAGE gel of the peak fraction indicated.
(C) Sedimentation equilibrium profiles of full-length ESCRT-I plotted as a distribution of A280 versus r at equilibrium. Data were collected at 6 (blue),
8 (green), 10 (purple), and 12 (red) krpm at a loading A280 of 0.38 (alternate data points are shown). The solid lines show the best-fit global analysis in
terms of a single ideal solute, with the corresponding residuals shown in the panels above the plot.
(D) Solution structural model of intact ESCRT-I. The curved arrows indicate that the Vps23 UEV and Vps28 C-terminal domain (CTD) are conforma-
tionally dynamic.RH = 5.45 nm for the heterotrimeric UEV-domain deletion
construct. Thus, when Mvb12 is not present, the solution
conformation of ESCRT-I is only modestly less extended
than the intact complex.490 Cell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc.The Stalk Is Important for the Function and Assembly
of ESCRT-I
To test the role of the stalk in ESCRT-I function, muta-
tions were engineered in Vps23, Vps37, and Mvb12.
Cell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc. 491Residues in the base, triple coiled coil, and hybrid
regions of the stalk were altered alone and in combi-
nation. A spectrum of effects was observed in various
mutants (Table S3). Some mutants, such as the com-
bined triple coiled coil and hybrid region mutant
vps23M254D/L286D (Figure S5), severely disrupted all
ESCRT-I functions by blocking the assembly of the com-
plex and destabilizing the subunits. Other mutations pro-
duced less drastic effects. We chose three representa-
tive alleles of this latter class for further study,
vps23M254D and mvb12L47D/I57D (triple coiled coil) and
vps37L67D (base). With the exception of reduced stability
of Mvb12 in vps37L67D strains, the different mutations
had little if any effect on steady-state levels of the other
subunits (Figure S1C). However, all three gave rise to de-
fects in the sorting of the MVB cargos Ste3 and Sna3
(Figure 5A). Some labeling of both cargos was observed
in the vacuolar lumen of the mutants, similar to that seen
in mvb12D cells. Vps37L67D and Vps23M254D mutations
also resulted in a CPY sorting defect at least as severe
as that of mvb12D mutants, whereas little CPY was
secreted from mvb12L47D/I57D mutants (Figure S1B;
Table S3).
We examined the effect of each mutation on ESCRT-I
membrane recruitment. Both Vps23M254D and
Mvb12L47D/I57D greatly reduced Mvb12 localization to the
MVB in vps4D strains (Figure 5B). However, Mvb12L47D/I57D
had little effect on the MVB localization of Vps23 in
either wild-type cells or vps4D mutants (Figure 5C),
suggesting this mutation reduces the assembly of
Mvb12 into the ESCRT-I complex without disrupting the
membrane association of ESCRT-I. In contrast, Vps37L67D
did not block the MVB association of either Mvb12 or
Vps23 (Figures 5B and 5C).
Coimmunoprecipitation experiments were used to test
the effect of each mutation on ESCRT-I assembly (Figures
5D–5F). The mutant complexes showed varying levels of
stability during copurification from native cell extracts.
Consistent with the in vivo localization data, Vps23M254D
and Mvb12L47D/I57D mutations had the greatest effect on
the incorporation of Mvb12 into the complex. Vps23M254D
blocked the Vps23-Mvb12 interaction and reduced, but
did not prevent, Vps23 binding to Vps37, whereas
Mvb12L47D/I57D showed reduced binding to both Vps23
and Vps37. Vps37L67D-containing complexes contained
wild-type levels of Mvb12 and Vps23, in keeping with
the MVB localization of both proteins.
These results indicate that the stalk contributes to the
function of the ESCRT-I complex in vivo. CPY secretion
of the mvb12L47D/I57D mutant was close to wild-type (Fig-
ure S1B), suggesting that perturbations of the stalk that do
not disrupt CPY sorting can nevertheless lead to signifi-
cant MVB cargo-sorting defects. Vps37L67D assembled
at near wild-type efficiency yet caused significant missort-
ing of CPY, Ste3, and Sna3. Thus, the base of the stalk is
less critical for assembly than the triple coiled coil or hy-
brid regions of the stalk, yet is equally important for cargo
sorting.Interactions of ESCRT-I with Model Membranes
In Vitro
To investigate the physical basis for the binding of ESCRT-
I to the endosomal membrane, we sought to define the
interactions responsible for its binding to membranes
in vitro. Full-length ESCRT-I bound to brain lipid and bound
weakly to synthetic PI(3)P-containing vesicles (Figures 6A
and 6B). No enhancement of binding was observed in
PI(3)P-containing vesicles compared to generic brain lipid
vesicles. No binding was observed in the Vps37 D1–21
construct, indicating that the basic N terminus of Vps37
is required for binding. ESCRT-II bound weakly to Folch
lipids (Figure 6A), but strongly to PI(3)P-containing syn-
thetic liposomes (Figure 6B), consistent with previous
findings (Teo et al., 2006). ESCRT-I and ESCRT-II were
mixed at a 1:1 ratio and found to bind weakly to Folch
but strongly to PI(3)P-containing synthetic liposomes.
These data show that ESCRT-I can bind weakly and non-
specifically to anionic lipids via the basic N terminus of
Vps37. In contrast, ESCRT-I and ESCRT-II together bind
strongly and specifically to a PI(3)P-containing model
membrane. The triple complex of Vps23:Vps28:Vps37
D1–21 bound to roughly the same extent as intact
ESCRT-I in the presence of ESCRT-II, indicating the loss
of Mvb12 does not affect the assembly of a membrane-
bound ESCRT-I/II complex (Figure 6C).
We developed an in vitro model MVB cargo based on
Cps1, which is ubiquitinated at Lys-8 (Katzmann et al.,
2001), 11 residues from the start of its transmembrane
helix. A construct in which ubiquitin was fused to Cps1
residues 8–17 followed by a unique C-terminal Cys resi-
due (Ub-Cps1[8–17]C) was covalently conjugated to lipo-
somes (Figure 6D). These liposomes, but not control
liposomes, bound to the ubiquitin-binding domains of
Rabex-5 (Figure 6E). The ability of ESCRT-I, -II, and the
ESCRT-I/-II complex to bind to PI(3)P-containing vesicles
was not substantially enhanced by the model cargo, con-
sistent with the low affinities of the ESCRT-I and -II ubiq-
uitin-binding domains. To explore whether Mvb12 alters
recruitment by Vps27, a ‘‘miniVps27’’ consisting of the
PI(3)P-binding FYVE domain, the ubiquitin-binding ubiqui-
tin-interacting motif domains, and the ESCRT-I-binding
P(S/T)XP sequences was purified. MiniVps27 binds to
PI(3)P-containing ubiquitin-Cps1-conjugated liposomes
(Figure 6E), but does not bind to control PC:PE liposomes
(data not shown). ESCRT-I binding to these liposomes
was markedly enhanced by the presence of miniVps27
(Figure 6E), independent of the presence or absence of
Mvb12. ThusMvb12 does not appear to regulate the inter-
action of Vps27 and ESCRT-I in vitro, consistent with the
absence of a structural interaction between Mvb12 and
the Vps27-binding UEV domain of Vps23.
DISCUSSION
The results presented here essentially complete the struc-
tural description of yeast ESCRT-I. The presence of a
130 A˚ long stalk is the most dramatic new feature of the
Figure 5. The Stalk Is Essential for ESCRT-I Function
(A) Ste3 and Sna3 sorting defects in stalk mutants. Plasmids expressing wild-type or mutant forms of VPS23,MVB12, or VPS37were introduced into
vps23D, mvb12D, or vps37D strains expressing plasmid-encoded Ste3-GFP or Sna3-GFP, as indicated.
(B) Mvb12 localization depends on the integrity of the stalk. Wild-type or mutant forms of VPS23 or VPS37 were expressed from plasmids in
vps23Dvps4D or vps37Dvps4D strains containing chromosomally integrated Mvb12-GFP, whereas plasmid-encoded wild-type and mutant forms
of Mvb12-YFP were expressed in mvb12Dvps4D strains.
(C) Stalk mutants do not prevent Vps23 localization to the MVB. Wild-type or mutant forms of VPS37 or MVB12 were expressed from plasmids in
vps37D, mvb12D, or mvb12Dvps4D strains containing chromosomally integrated Vps23-GFP.
(D–F) Stalk mutations have differential effects on ESCRT-I assembly. In (D), detergent extracts from vps23D mutants containing chromosomally
tagged Mvb12-GFP (upper panels) or Vps37-13myc (lower panels) and plasmids for the expression of HA-tagged wild-type or mutant forms of
Vps23 were subjected to immunoprecipitation with anti-HA antiserum (E) mvb12D mutants containing chromosomally tagged Vps23-6HA (upper
panels) or Vps37-13myc (lower panels), and plasmid-borne wild-type or mutant forms of Mvb12-YFP were immunoprecipitated with either anti-
HA (upper panels) or anti-myc (lower panels) antiserum. In (F), vps37D mutants containing chromosomally tagged Mvb12-GFP (upper panels) or
Vps23-6HA (lower panels) and plasmids for the expression of wild-type or mutant forms of Vps37-myc were immunoprecipitated with anti-myc
antiserum. Coprecipitating proteins were resolved by SDS-PAGE and analyzed by western blotting with mAbs to HA, myc, or GFP as indicated.
Immunoprecipitates from cells expressing wild-type VPS23 (D) or VPS37 (F) were loaded at 53 (D) or 23 (F) reduced levels relative to immuno-
precipitates from cells expressing empty vector or mutant proteins to compare relative levels of copurifying proteins despite differences in the stability
of the mutant complexes. Bar = 2 mM.492 Cell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc.
Figure 6. Sedimentation of ESCRT-I with Model Liposomes In Vitro
(A) ESCRT-I has aweak intrinsic ability to bind to synthetic PI(3)P-containing liposomes that depends on the N-terminal helix of Vps37. ESCRT-II binds
strongly to these liposomes and recruits ESCRT-I in vitro independent of the Vps37 N-terminal helix.
(B) ESCRT-I sediments with brain liposomes, indicating the interaction with the N-terminal helix, does not require PI(3)P. ESCRT-I Vps37 D1-21 does
not bind to brain liposomes, showing that the stalk and headpiece do not bind lipids.
(C) The triple ESCRT-I complex with the Vps37 D1–21 deletion (EI3) is compared to intact ESCRT-I for binding to synthetic PI(3)P-containing lipo-
somes. Both complexes are recruited to the same extent by ESCRT-II.
(D) Schematic of Mini-Vps27 and Ub-Cps1(8–17)C Constructs.
(E and F) Sedimentation with ubiquitin-Cps1 linker-conjugated synthetic PI(3)P-containing liposomes, schematized in (F). ESCRT-II and mini-Vps27
bind to these liposomes. ESCRT-I and triple ESCRT-I do not bind in the absence of other complexes but bind strongly in the presence of ESCRT-II and
more weakly in the presence of mini-Vps27.heterotetramer structure. Known structures of the yeast
Vps23 UEV (Teo et al., 2004b) and Vps28 C-terminal do-
mains (Pineda-Molina et al., 2006), together with the het-
erotetrameric core presented here, represent 88% of the
mass of the complex, missing only flexible loops linking
the UEV and Vps28 C-terminal domains and functionallynonessential extensions from the termini of Vps37 and
Mvb12. Hydrodynamic analyses show that the UEV and
Vps28 C-terminal domains are in an open conformation,
constrained only by their fully flexible tethers to the core.
This core-and-appendage organization is familiar in other
contexts such as the adaptor protein-2 complex (CollinsCell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc. 493
Figure 7. Membrane-Docked Model for ESCRT-I
(A) Structural model for yeast ESCRT-I docked to an endosomal membrane. The GLUE domain (PDB code 2CAY) (Teo et al., 2006) and NZF1 domain
of ESCRT-II (PDB code 2J9U) (Gill et al., 2007) are cyan, ubiquitinated Cps1 is red, and ESCRT-I subunits are colored as in Figures 2–4.
(B) Schematic diagram of the docked model, incorporating simplified models of the interacting Vps27/Hse1 and ESCRT-II complexes.et al., 2002). The combination of crystallographic analysis
of the core and domains separately with hydrodynamic
analysis illustrates the power of hybrid structural method-
ology to address challenging structural problems.
A Structural Model for ESCRT-I on the Membrane
In order to model ESCRT-I bound to an endosomal mem-
brane, we inventoried its physical interactions with the
membrane. Consistent with a lack of known phospho-
inositide-binding domains, we found that ESCRT-I binds
acidic phospholipids to a modest extent, but does not
bind specifically to PI(3)P (Figures 6A and 6B). The highly
basic N-terminal 21 amino acids of Vps37, which are ab-
sent in the crystallized construct, are required for the
weak binding to acidic phospholipids in vitro, although
they are not essential for ESCRT-I function and localization
in vivo (not shown).When ESCRT-I and full-length ESCRT-II
aremixed, ESCRT-I associates tightly with PI(3)P-contain-
ing liposomes. However, the interaction with ESCRT-II
is insufficient to target ESCRT-I in vivo in the absence of
Vps27, even though it can do so in vitro. We also found
that ESCRT-I can assemble withmodel cargo and amodel
Vps27 protein on PI(3)P-containing liposomes in the ab-
sence of ESCRT-II. The model Vps27 used is less potent
than ESCRT-II at recruiting ESCRT-I in vitro, which may
reflect the limitations of the model system.
The orientation of ESCRT-I on the endosomal mem-
brane can be inferred from the heterotetramer core struc-
ture, the known interactions of the UEV and Vps28
C-terminal domains, and the Vps37 N-terminal helix inter-
action with membranes. The ubiquitination of the ESCRT-I
substrate Cps1 11 residues from the start of its trans-
membrane helix shows that the UEV domain is capable
of functional ubiquitin binding very near the membrane.494 Cell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc.The NZF1 zinc finger, which is inserted within the split
GLUE domain of the ESCRT-II subunit Vps36, binds to
the ESCRT-I Vps28 C-terminal domain, while the GLUE
domain itself binds to membrane-embedded PI(3)P (Teo
et al., 2006). This dictates proximity of the Vps28 C-termi-
nal domain to the membrane. The interaction between the
Vps37 basic N-terminal segment and acidic phospho-
lipids suggests that this part of the complex also contacts
themembrane. Taken together, these constraints align the
stalk roughly parallel to the plane of the membrane
(Figure 7).
Function of the Stalk
The stalk is formedby three of the four subunits of ESCRT-I,
and within these three subunits, residues that participate
in intersubunit contacts were selected for mutagenesis.
Mutations within the triple-helical stalk region of Mvb12
or Vps23 reduced the assembly of Mvb12 into the
ESCRT-I complex and led to sorting defects similar to
those of cells lacking Mvb12. Simultaneous mutation of
two different regions of the Vps23 stalk appears to desta-
bilize the entire ESCRT-I complex by disrupting the asso-
ciation of Vps23 with both Vps37 and Mvb12, accounting
for the abrogation of sorting of all cargo tested. Taken to-
gether, the Vps23 and Mvb12 mutant data show that the
integrity of the stalk is important for the stability and as-
sembly of the complex. However, mutation of Vps37 at
the base of the stalk had only mild effects on the stability
and assembly of ESCRT-I subunits, yet still disrupted the
sorting of CPY, Ste3, and Sna3. This result implicates the
stalk in cargo sorting independent of its roles in ESCRT-I
stability or assembly.
The postulate that Mvb12 has a central role in organiz-
ing ESCRT-I structure begs the question as to why the
phenotype of mvb12 is milder than that of other ESCRT-I
subunits. Mvb12 is not essential for headpiece assembly
(Kostelansky et al., 2006; Teo et al., 2006) and has only
one clear-cut function: to increase the stability of the stalk.
Vps23 and Vps37 are as important for stalk formation as
Mvb12, but in contrast to Mvb12, they are also required
for headpiece assembly, which is in turn required to inte-
grate Vps28 into the complex. The solution structure of
heterotrimeric ESCRT-I in the absence ofMvb12 is still ex-
tended, although it is not as extended as intact ESCRT-I,
and it is destabilized as judged by limited proteolysis (Kos-
telansky et al., 2006). The presence of some residual ex-
tended structure in the absence of Mvb12 is consistent
with the residual function and stability of ESCRT-I in the
absence of Mvb12. The stalk regions of yeast Vps23 and
Vps37 are conserved in their human orthologs (Figures
3E, S3, and S4). Human Vps23 (Tsg101) and Vps37B/C
are required for HIV budding on the basis of knockdown
studies (Garrus et al., 2001; Eastman et al., 2005), and
mutations within the triple coiled-coil and hybrid regions
of human Vps23 block budding of HIV (Martin-Serrano
et al., 2003). There is thus likely to be a human counterpart
to Mvb12, although its identity is unclear. Thus the stalk is
a structurally and functionally conserved feature of
ESCRT-I from yeast to humans.
Function of Mvb12
While this paper was under review, three other laborato-
ries reported the identification of Mvb12 as an ESCRT-I
component (Curtiss et al., 2006; Oestreich et al., 2006;
Chu et al., 2006;). Each of these three reports emphasizes
a different biological function for Mvb12. Babst and
coworkers note that Mvb12 is required for the efficient re-
cycling of ESCRT-I from membranes in addition to its role
in sorting (Curtiss et al., 2006). Katzmann’s group sug-
gests a cargo-selective role for Mvb12 based on their ob-
servation that trafficking defects inmvb12D cells are more
severe for some cargo than others (Oestreich et al., 2006).
Two major models have been put forward to account for
the differential effects ofmvb12 deletion on various cargo
(Curtiss et al., 2006; Oestreich et al., 2006). In the first,
Mvb12 has a direct cargo-selective adaptor role, while in
the second model, cargo-dependent defects reflect the
existence of two or more partially separate MVB path-
ways. At this stage, there are no data to decisively favor
one model over the other, and this is an important area
for further study.
Emr and coworkers have proposed that Mvb12 pro-
motes trimerization of soluble ESCRT-I in yeast cytosol
and that its biological function is to inhibit the ESCRT-I/
ESCRT-II interaction (Chu et al., 2006). However, the
soluble form of ESCRT-I is a monomer of 1:1:1:1 subunit
stoichiometry, not a trimer (Figures 2 and S2; Table S2).
We found that Mvb12 does not affect the binding of
ESCRT-I/ESCRT-II to membranes, and Williams and co-
workers found that Mvb12 has no effect on the affinity of
ESCRT-I for ESCRT-II in solution (Gill et al., 2007). This
is consistent with our structural finding that the Vps28C-terminal domain, which binds to ESCRT-II, does not
interact with Mvb12 and is therefore unlikely to be regu-
lated by Mvb12. Taken together, the available data argue
against the concept that Mvb12 has as its main function
the direct regulation of ESCRT-I/ESCRT-II binding. In-
stead, the accumulated biological, biochemical, and
structural data onMvb12 aremost consistent with amodel
in which it is an integral component of the core structure of
ESCRT-I whose main role is to stabilize the stalk.
Membrane trafficking is an inherently mechanical pro-
cess. Rigid rod- and stalk-like molecules are omnipresent
in trafficking pathways. The coiled-coil stalk structures in
proteins such as EEA1 (Dumas et al., 2001) are oriented
normal to membranes and tether vesicles to each other
or to organelles. Elongated structures in membrane-
binding and -coat proteins are oriented parallel to the
membrane surface. The elongated BAR domains of pro-
teins such as amphiphysin contact the membrane directly
(Peter et al., 2004), while the clathrin leg is part of a scaffold
that organizes membrane-bound structures without
contacting the membrane directly (Brodsky et al., 2001;
Kirchhausen, 2000). The dockedmodel of ESCRT-I places
the stalk parallel to the plane of the membrane, but not in
direct contact with it. In thismodel, the stalk spatially orga-
nizes interactions at the membrane by imposing physical
restrictions on their distances relative to each other, yet
does not contact the membrane directly.
Lumenal vesicles in yeast multivesicular bodies have
a mean diameter of 24 nm (Nickerson et al., 2006). Several
ESCRT pathway components have rigid, elongated struc-
tureswhose lengths are of the same order of magnitude as
the lumenal vesicles themselves. These include the
ESCRT-I core at 18 nm, ESCRT-II at 15 nm (Hierro et al.,
2004; Teo et al., 2004a), and the Bro1 domain at 10 nm
(Kim et al., 2005). Strikingly, although perhaps coinciden-
tally, the maximum dimension of intact ESCRT-I in solu-
tion is 25 nm, remarkably close to the mean diameter
of a yeast MVB luminal vesicle. A key role for the stalk is
most consistent with a function for ESCRT-I as a sophisti-
cated machine acting in coordination with other rigid,
elongated ESCRT components.
Conclusion
We have developed a comprehensive structural model for
the intact ESCRT-I complex with a number of ramifica-
tions for ESCRT function. Our results favor a model in
which Mvb12 is an integral component of ESCRT-I. The
UEV and Vps28 C-terminal domains have substantial free-
dom to diffuse in search of their interaction partners, re-
stricted only by their tethers. This structural model is con-
sistent with the lack of any observed effect of Mvb12 on
the binding of ESCRT-I to membranes, ubiquitin, Vps27,
or ESCRT-II in vitro. ESCRT-I interacts only weakly with
membranes and ubiquitin and is thus not recruited to
endosomes in the absence of targeting by Vps27. The
observation that all ESCRT ubiquitin-binding domains
interact with the same Ile-44 patch on ubiquitin led to
the ‘‘hand-off’’ model in which ESCRT complexesCell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc. 495
sequentially bind to cargo (reviewed by Hurley and Emr,
2006). The structure shows that a rigid stalk holds the
ESCRT-I and ESCRT-II ubiquitin-binding sites too far
apart for direct hand off, strongly arguing against hand
off between ESCRT-I and II. We favor an alternative model
in which an assembly of multiple ESCRT complexes si-
multaneously binds to multiple ubiquitinated cargo mole-
cules. The structure of the trimeric ESCRT-I headpiece
(Kostelansky et al., 2006; Teo et al., 2006) revealed a glob-
ular 6 nm structure consistent with a simple role as an as-
sembly hub, linking domains that bound cargo and other
ESCRT complexes. We now find that the core is nearly
18 nm long and the intact complex is25 nm long. It is dif-
ficult to rationalize the evolution of such an elongated
structure merely to assemble the subunits. The shape
and size of ESCRT-I favor a model in which ESCRT-I
directly participates in regulating mechanical aspects of
cargo recruitment and membrane remodeling.
EXPERIMENTAL PROCEDURES
Fluorescence Microscopy
Wild-type and mutant strains expressing chromosomally integrated
Mvb12-GFP or Vps23-GFP were labeled with FM4-64 and viewed by
double-label fluorescence microscopy of fixed cells. Uptake of
40 mMFM4-64 by live cells was performed at 30C for 1 hr, after which
cells were resuspended in YPD and incubated for 1 hr at 30C. Cells
were washed twice in 1M Tris pH 8.0 containing 1% sodium azide
and 1% sodium fluoride before imaging. Live and fixed cells were
imaged with a 1003 oil-immersion objective on a Zeiss Axioplan2
fluorescencemicroscope, and images were captured with a CoolSnap
camera using MetaMorph software and adjusted using Adobe
Photoshop.
Coprecipitation Experiments and Western Blotting
Log phase cells were converted to spheroplasts and stored at 70C
(Conibear and Stevens, 2002). For immunoprecipitation of Vps23,
spheroplasts from either 20 OD600 or 100 OD600 of cells were resus-
pended in 1 ml of lysis buffer (600 mM sorbitol, 20 mM HEPES at pH
7.2, 50 mM KCl, 100 mM potassium acetate, 1% TX-100). Lysates
were incubated with 2 ml of either rabbit anti-HA antiserum or rabbit
anti-myc antiserum for 1 hr at 4C and then with protein G sepharose
(Amersham) for 1 hr at 4C. The pellets were washed three times in
20 mM HEPES at pH 7.2 and 50 mM KCl and subjected to SDS-
PAGE. Coprecipitated proteins were detected by western blotting
with monoclonal antibodies to HA (HA.11, Covance Research Prod-
ucts), GFP (Roche scientific), or myc (4A6, Upstate) followed by
HRP-labeled anti-mouse secondary antibody (Jackson Immuno-
Research or Sigma). Blots were developed with enhanced chemilumi-
nescence and either exposed to film (X-OMAT LS, Kodak), or
luminescent images were captured with a Fluor-S MAX MultiImager
and analyzed using Quantity One software.
Crystal Structure Determination
Crystals of the ESCRT-I heterotetramer were grown at 21C by hang-
ing drop vapor diffusion mixing 2 ml of 4 mg/ml protein in 50 mM Tris
(pH 7.4), 150 mM NaCl, 5 mM DTT with an equal volume of 100 mM
citric acid (pH 4.0), and 800 mM ammonium sulfate. Phases were
calculated by combining a 3.6 A˚ two wavelength SeMAD data set
with multiple isomorphous replacement data from 3.0 A˚ gold and
platinum derivative data sets. The structure was refined against a
2.7 A˚ native data set, as described in the Supplemental Data.496 Cell 129, 485–498, May 4, 2007 ª2007 Elsevier Inc.Hydrodynamic Modeling
All calculations of hydrodynamic properties from structural coordi-
nates were carried out using Hydropro (Garcia de la Torre et al.,
2000). Details of the procedure are described in the Supplemental
Data.
Liposome-Binding Experiments
Liposomes used for this study are as follows: Folch fraction (Sigma),
80% POPC:20% POPE (Avanti Polar Lipids), 77% POPC:20%
POPE: 3% PI(3)P (Echelon), 77% POPC:15% POPE: 5% MPB-PE
(1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimido-
phenyl)butyramide]; Avanti Polar Lipids):3% PI(3)P. The liposomes
were prepared at a total lipid concentration of 1 mg/ml by evaporating
the solvent from the desired lipid mixture using a nitrogen stream. The
dried lipids were resuspended in 150 ml of 0.3 M sucrose, and the so-
lution was incubated at room temperature under nitrogen for 1 hr with
periodic vortexing; 1 ml of water was added, and the sample was sedi-
mented in an ultracentrifuge at 17,000 3 g for 30 min at 4C. The su-
pernatant was removed, and the pellet was frozen and thawed three
times using liquid nitrogen to break up large particles. The pellet was
dissolved in 1 ml of buffer A (10 mM HEPES at pH 7.4 and 150 mM
NaCl) and extruded 15 times through a 0.1 mm filter. To chemically
conjugate Ub-Cps1(8–17)C to the liposome (77% POPC:15% POPE:
5% MPB-PE: 3% PI[3]P), 450 mg of Ub-Cps1(8–17)C was added to
850 ml of 1 mg/ml solution of total lipids and incubated at room temper-
ature for 3 hr. The supernatant was removed by sedimentation at
128,0003 g at 4C for 1 hr, washed with 1 ml of the buffer A, and sedi-
mented for 1 hr. The pellet was resuspended in 850 ml of the buffer A.
For binding experiments, 50 mg of the liposomes were mixed with
50 mg of protein and were brought up to a total volume of 200 ml with
buffer A, incubated at room temperature for 30 min, and sedimented
at 128,000 3 g at 4C for 30 min. The pellet was washed once with
200 ml of the buffer A and again sedimented for 30 min. Samples of
the supernatant (15 ml) and pellet were analyzed by SDS-PAGE. As
a control for ubiquitin binding, the tandem A20 ZnF-MIU domain con-
struct of Rabex-5 was used (Lee et al., 2006). This Rabex-5 construct
runs on SDS-PAGE at the same position as lipid-conjugated
Ub-Cps1(8–17)C, but binding is clearly visualized by an increase in
the intensity of the Coomassie blue-stained band. To further confirm
that the lipid-conjugated Ub-Cps1(8–17)C was functional, surface
plasmon resonance experiments were carried out with liposomes
bound to an L-1 chip using a Biacore T-100 instrument. Rabex-5
A20 ZnF-MIU bound with 10 mM affinity (S.L. and J.H.H., unpublished),
consistent with previous surface plasmon resonance analysis using
immobilized GST ubiquitin (Lee et al., 2006).
Supplemental Data
Supplemental Data include five figures, four tables, Supplemental
Experimental Procedures, and Supplemental References and can be
found with this article online at http://www.cell.com/cgi/content/full/
129/3/485/DC1/.
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